Do we really need another biomarker to diagnose myocardial infarction after coronary artery bypass graft surgery?

Anesth Analg. 2010 Nov;111(5):1086-7. doi: 10.1213/ANE.0b013e3181f4db4c.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Biomarkers / blood
  • Coronary Artery Bypass / adverse effects*
  • Coronary Artery Bypass / mortality
  • Creatine Kinase, MB Form / blood
  • Fatty Acid Binding Protein 3
  • Fatty Acid-Binding Proteins / blood*
  • Humans
  • Myocardial Infarction / blood
  • Myocardial Infarction / etiology*
  • Myocardial Infarction / mortality
  • Myoglobin / blood
  • Predictive Value of Tests
  • Risk Assessment
  • Risk Factors
  • Time Factors
  • Treatment Outcome
  • Troponin I / blood
  • Ventricular Dysfunction, Left / blood
  • Ventricular Dysfunction, Left / etiology
  • Ventricular Dysfunction, Left / mortality

Substances

  • Biomarkers
  • FABP3 protein, human
  • Fatty Acid Binding Protein 3
  • Fatty Acid-Binding Proteins
  • Myoglobin
  • Troponin I
  • Creatine Kinase, MB Form